Regulatory News:
Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd. (ticker: PSH:NA) has updated its Schedule 13D with the United States Securities and Exchange Commission, disclosing that various funds it manages increased their beneficial ownership of Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX), to 9.9% of shares outstanding.
About Pershing Square Holdings, Ltd.
Pershing Square Holdings, Ltd. (PSH:NA) is an investment holding company structured as a closed end fund that makes concentrated investments principally in North American companies.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151123006320/en/
Contacts:
MEDIA:
StockWell Communications
Tim Burt, +44 (0)20 7240 2486
Tim.Burt@stockwellgroup.com
